Takeda (Netherlands)
Hoe versterken we de plasmageneesmiddelenketen? Beleidsadvies van expertsHoe versterken we de plasmageneesmiddelenketen? Beleidsadvies van expertsCalendar4 december 2025Nieuwe toedieningsvorm Takhzyro® (Lanadelumab) 300 mg oplossing voor injectie in voorgevulde penNieuwe toedieningsvorm Takhzyro® (Lanadelumab) 300 mg oplossing voor injectie in voorgevulde penCalendar27 november 2025Takeda steunt Stichting Steun Emma Kinderziekenhuis met donatie voor innovatie en onderzoek in de zorg.
Basic Information
- Category: business
- Website: http://www.takeda.nl/
Documented Facts
- Email: media_relations@takeda.com (No linked source recorded for this statement.)
Evidence and Sources
- Takeda (Netherlands) — Official Site (official)
- Takeda (Netherlands) on linkedin (social)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Takeda (Netherlands).
- Canonical profile: https://brandsource.ai/brands/takeda-netherlands
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/takeda-netherlands/json-ld
- Citation profile API: https://brandsource.ai/api/brands/takeda-netherlands/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (81/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Hoe versterken we de plasmageneesmiddelenketen? Beleidsadvies van expertsHoe versterken we de plasmageneesmiddelenketen? Beleidsadvies van expertsCalendar4 december 2025Nieuwe toedieningsvorm Takhzyro® (Lanadelumab) 300 mg oplossing voor injectie in voorgevulde penNieuwe toedieningsvorm Takhzyro® (Lanadelumab) 300 mg oplossing voor injectie in voorgevulde penCalendar27 november 2025Takeda steunt Stichting Steun Emma Kinderziekenhuis met donatie voor innovatie en onderzoek in de zorg.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 supporting source linked.
- 1 structured fact available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.